• 1. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 2. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 3. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 4. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 5. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Methylpyridines

Research Brief on 1-(3-methyl-2-pyridinyl)ethanamine (CAS: 780803-63-6) in Chemical Biology and Pharmaceutical Applications

1-(3-methyl-2-pyridinyl)ethanamine (CAS: 780803-63-6) is a pyridine derivative that has garnered significant attention in recent chemical biology and pharmaceutical research due to its potential as a versatile building block for drug discovery and development. This compound, characterized by its methyl-substituted pyridine core and ethanamine side chain, exhibits unique physicochemical properties that make it an attractive scaffold for medicinal chemistry applications. Recent studies have explored its role in the synthesis of novel bioactive molecules targeting various disease pathways.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of 1-(3-methyl-2-pyridinyl)ethanamine as a key intermediate in the synthesis of selective kinase inhibitors. The research team utilized this compound to develop a series of potent and selective inhibitors targeting the JAK-STAT signaling pathway, which plays a crucial role in inflammatory diseases and certain cancers. The structural flexibility of the pyridine ring system allowed for optimal interactions with the kinase ATP-binding site, while the ethanamine moiety provided necessary solubility properties for drug-like characteristics.

In neuropharmacology research, 1-(3-methyl-2-pyridinyl)ethanamine has shown promise as a precursor for the development of novel central nervous system (CNS) agents. A 2024 study in ACS Chemical Neuroscience reported its incorporation into dopamine receptor modulators with improved blood-brain barrier penetration compared to traditional analogs. The methyl group at the 3-position of the pyridine ring was found to significantly influence receptor binding affinity and selectivity, suggesting structure-activity relationships worth further exploration.

The compound's application extends to antimicrobial drug development, where researchers have leveraged its chemical structure to create novel antibacterial agents. Recent work published in Bioorganic & Medicinal Chemistry Letters (2023) described derivatives of 1-(3-methyl-2-pyridinyl)ethanamine that exhibit potent activity against multidrug-resistant Gram-positive pathogens, including MRSA strains. The mechanism of action appears to involve disruption of bacterial cell wall biosynthesis, with the pyridine moiety playing a critical role in target recognition.

From a synthetic chemistry perspective, 1-(3-methyl-2-pyridinyl)ethanamine has proven valuable in asymmetric synthesis and chiral auxiliary applications. A 2024 report in Organic Letters highlighted its use in the preparation of enantiomerically pure β-amino alcohols, which serve as important intermediates for various pharmaceutical compounds. The CAS: 780803-63-6 compound's stability under diverse reaction conditions makes it particularly useful for multi-step synthetic routes in complex molecule construction.

Ongoing research continues to explore the full potential of 1-(3-methyl-2-pyridinyl)ethanamine in drug discovery. Current investigations include its incorporation into PROTACs (Proteolysis Targeting Chimeras) for targeted protein degradation and its use in the development of radiopharmaceuticals for diagnostic imaging. The compound's versatility and favorable drug-like properties position it as a valuable tool in modern medicinal chemistry, with potential applications across multiple therapeutic areas.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)